The single pass extraction of ammonia (E) by cerebral capillaries was studied in vivo in rhesus monkeys with 1S N. The value of E for 13 N-ammonia was found to be less than 100%, inversely related to cerebral blood flow and to be limited by the permeability of the blood brain barrier for ammonia. A value of the permeability surface area product was determined to be 0.0040 cm 3 /sec/gm. The single pass extraction fraction, E, for 13 N-ammonia was found to be independent of arterial blood pH (in the range of 7.2 to 7.6) and of arterial blood ammonia concentration (in the range of 80-1400 ngms/100 ml). An insulin induced hypoglycemic reduction in the cerebral metabolic rate for glucose and oxygen of 54% produced a reduction in E of about 24%. When a condition of elevated arterial blood ammonia was added to hypoglycemia, the value of E and cerebral metabolic rate for oxygen remained low while the cerebral metabolic rate for glucose increased by a factor of 2.2 indicating the presence of a detoxification shunt for ammonia. Positron tomographic images of the equilibrium cross section distribution of 13 N-ammonia appeared to reflect regional differences in variations of capillary density that are found in the cerebral tissue.
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THE DEVELOPMENT of positron computed tomography (PCT) has increased interest in the use of compounds labeled with positron-emitting radionuclides for the study of hemodynamics and metabolism.
1 " 4 PCT is capable of providing cross-sectional images of the quantitative tissue concentration subsequent to administration of a labeled compound and in this sense represents an in vivo analogy to the in vitro technique of quantitative autoradiography. The effective use of this technique requires the understanding of the factors which affect the distribution, transport, retention, metabolism and clearance of the injected compound. Ammonia labeled with the positron-emitting radionuclide of 13 N ( 13 N-ammonia*) has been used in a conventional imaging format and more recently with PCT to identify ischemic regions of myocardial 5 " 10 and cerebral tissue. 9 " 11 The ischemic region is identified by the lack of uptake and/or retention of 13 N-ammonia. In addition to the previous studies, Phelps et al. 9 using PCT with normal volunteers, have shown high uptake of l3 N-ammonia in cerebellum, brain stem and cortex relative to subcortical white matter. The relative values of uptake appear to be in good agreement with the relative capillary densities and/or blood flows of these structures. 9 However, whether the uptake is directly related to capillary density or blood flow and what other factors affect 13 N-ammonia uptake and retention in cerebral tissues is poorly understood. At present there are no studies in the literature which address this subject in detail.
To investigate this problem further, we have used rhesus monkeys and single pass (carotid bolus injections) studies to determine the extraction fraction, tissue retention time and permeability coefficient for l3 N-ammonia in cerebral tissue. The effect of arterial blood pH, elevated arterial blood ammonia concentration, reduced arterial blood glucose and elevated blood ammonia on the cerebral tissue extraction of 13 N-ammonia was also investigated.
Methods
The fraction of 13 N-ammonia extracted by cerebral tissue was determined subsequent to the internal carotid artery (ICA) injection of 0.2 ml 13 N-ammonia in adult rhesus monkeys. The measurement of cerebral blood flow (CBF) accompanying the measurement of extraction fraction (E) of 13 N-ammonia utilized residue detection 12 of a bolus (0.2 ml) of l33 Xe injected into the ICA.
To facilitate the injection of radioisotopes into the ICA the monkeys were anesthetized with phencyclidine (2mg/kg) at least 2 weeks prior to experimentation and the right external carotid artery was ligated at its origin. Radioisotope injections were then made through a small (.021cm diam) catheter positioned in the common carotid artery under fluoroscopic control at the time of experimentation. For the experiments, the monkeys were again anesthetized with phencyclidine (2mg/kg), paralyzed with gallamine, intubated with a cuffed endotracheal tube, and passively ventilated on 100 percent oxygen using an animal respirator. Anesthesia was maintained throughout the experiments by supplemental doses of phencyclidine (lmg/kg) hourly. The injection catheter was then inserted in the femoral artery and its tip positioned in the right common carotid artery under fluoroscopic control. To prevent clotting of this catheter system, which was used for injection of radioisotopes, monitoring arterial blood pressure, and sampling arterial blood, all animals were anticoagulated with heparin at the beginning of the experiment. The end tidal Pco 2 , arterial blood pressure (except for brief periods necessary for isotope injection or blood sampling) and rectal temperature were monitored continuously. Rectal temperature was maintained between 37-39° C with a heating pad. Arterial pH, Pco 2 and Po 2 were measured before and after each injection of radioisotope. A catheter placed in the femoral vein was used for the infusion of acids, bases, NH 4 HCO 3 and insulin. Blood ammonia (plasma) concentration was measured calorimetrically using a commercially available kit (HYLAND). Arterial and venous blood samples for the measure of glucose and oxygen consumption were obtained, respectively, from the catheter placed in the ICA and either the jugular bulb or a direct puncture of the superior sagittal sinus via a Teflon appliance chronically implanted through a small craniectomy directly over the sinus. The arterial and venous glucose concentrations were analyzed by standard enzymatic techniques in triplicate.
Isotope Preparation

13
N was produced in the Washington University medical cyclotron by a 12 C (d,n) 13 N reaction on methane gas. The preparation of 13 N-ammonia has been described elsewhere. 13 The radiochemical purity of these samples was determined by liquid and gas chromatography to be greater than 97% 13 N-ammonia and to contain less than 10~4M of carrier ammonia per ml of injected solution.
133
Xe in saline was used as a diffusable tracer for the measurement of CBF (supplied by Mallinckrodt Chemical, St. Louis, MO).
Isotope Detection
The time course curve of each tracer through the brain was measured by means of a 7.5 X 5cm Nal (Tl) scintillation detector which was shielded, collimated and placed under the head of the rhesus monkey so the whole brain could be viewed with approximately uniform detection efficiency. Two single channel pulse height analyzers were used to set energy windows on the full energy gamma-ray peaks of the 81 and 511 KeV radiation emitted from 133 Xe and 13 N, respectively. The output of the SCA's was routed into an on-line computer for data collection and analysis. Optimum time resolution and statistical accuracy were achieved by using 0.1 second time sampling initially and peak counting rates from 2,000 to 10,000 counts/second.
Measurements and Calculations
The fraction (E) of 13 N-ammonia extracted by the brain during a single capillary transit was determined by graphically extrapolating the relatively slow clearance of the portion of 13 N-ammonia extracted into tissue back to the maximum of the perfusion peak and then computing the ratio E = B/A as shown in figure 1 . The validity and accuracy of this approach has been discussed elsewhere."
The cerebral blood flow was determined by utilizing the 10-min height/area residue detection of a bolus of 133 Xe injected into the ICA. 12 A value of 1.10 ml/gm was used for the whole brain-blood partition coefficient for xenon 15 to yield the cerebral blood flow in ml/min/lOOgms. The final value of cerebral blood flow was calculated assuming that the 133 Xe 10-min height/area method systematically overestimates flow by 11%. 16 The brain permeability for 13 N-ammonia was determined using the single capillary model proposed by Renkin 17 and Crone 18 This model can be written in the form:
where E is the extraction fraction of a diffusable substance, P is the permeability of the substance, S is the surface area of the capillary and F is the blood flow through the capillary (in this case the cerebral blood flow). Thus from the experimental measurement of the extraction fraction, E, and CBF, we can calculate the brain capillary permeability coefficient-surface area product, PS, for 13 N-ammonia. The values of the cerebral metabolic rate for glucose (CMRGlu) and oxygen (CMRO 2 ) were calculated using a standard Fick technique as discussed in detail elsewhere. 20 Experimental Procedures
E versus CBF
The extraction fraction for 13 
E versus Blood pH
Experiments were performed to examine the effect on E from changes in the ratio of N H 3 / N H / in arterial blood by altering blood pH. The blood pH was varied in 3 rhesus monkeys by infusing 0.2 N HC1 or 0.2 N NaOH through a femoral vein catheter at a rate of 40 to 100 drops per minute. The arterial blood pH was monitored for about 15 minutes to assure a steady state before 13 NH 3 injections were performed. Arterial blood gases and blood plasma ammonia concentration were measured before and after each measurement of E. Pa CO2 was maintained constant to avoid changes in CBF.
E versus Blood Ammonia Concentration
Experiments were carried out with three rhesus monkeys to examine the effect of elevated blood ammonia concentration on E. A base line measurement of E was made and blood ammonia concentration was increased by infusion of 0.16 M NH4HCO3 through a catheter in the femoral vein at a rate of 10 to 30 drops per minute. E was measured about 30 minutes after the start of the infusion and arterial blood samples were taken for measurement of blood gas, pH and plasma ammonia concentration before and after each measurement of E.
E versus Glucose and Oxygen Utilization and Blood Ammonia Concentration
Experiments were also carried out to examine the effect on E of decreased glucose utilization at normal and elevated blood ammonia concentration. CBF and E were measured at a base line cerebral glucose (CMRGlu) and oxygen (CMRO 2 ) metabolism and then E was measured after a) the animal was given 40 units of insulin/kg to reduce the blood glucose level and b) with the animal still in hypoglycemia, the blood ammonia concentration was increased by the intravenous infusion of 0. 
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FIGURE 1. Time course of activity in brain subsequent to internal carotid bolus injection of0.2cc of'Nammonia in rhesus monkey. CBF was 59 ml/min/IOOgm and extraction fraction was 28%. A) First 70 sec portion of clearance curve showing the components of extracted, non-extracted (vascular) and recirculating activity. Extraction fraction E = B/A. B) Twenty minute portion of clearance curve showing the slow turnover rate of the extracted portion oj""A'-ammonia (Ty, = 45min).
CBF, blood samples were taken from the ICA and the superior saggital sinus (animals 1, 2 and 4, table 4) or jugular bulb for the measurement of blood gas, glucose and plasma ammonia concentration.
Results
A typical clearance curve from an ICA injection of a 0.2cc bolus of I3 N-ammonia is shown in figure 1 . This clearance curve consists of three components: a) a rapidly clearing fraction with a mean transit time of 2.9 seconds which is consistent with a vascular component at the measured flow of 59 ml/min/lOOgms of this study, 21 b) a slow component with a halftime of about 40 to 50 minutes which results from the fraction of "N-ammonia extracted into the tissue, and c) a small third component which probably results from recirculation of the tracer.
Permeability Coefficient
The data from the measurements of E during CO 2 tension induced changes in CBF are shown in table 1. The inverse relationship between E and CBF is shown in figure 2A . These data can be fit with a linear equation (P < 0.001) but appear to exhibit a non-linear relationship as would be predicted from equation 2. A plot of In (1 -E) versus (CBF) 1 for the determination of the PS product (eq. 2) is shown in figure 2B . These data were analyzed by linear regression analysis to yield the equation:
To be consistent with the conventional permeability nomenclature in the literature, in which indicator concentrations are expressed per milliliter of solvent water on both sides of the blood brain barrier, the value of CBF can be converted to flow rate of blood water (F w ). The water content of blood is approximately 0.81 ml per ml of blood for most animals and changes only slightly with the hematocrit. 22 Thus eq. 3 can be rewritten as:
In (1 -E) = 0.09 -24/F
with a correlation coefficient of 0.94 (P < 0.001). Thus equation 3 predicts a brain capillary PS product of 24 ml/min/lOOgms or 0.0040 cm 3 /sec/g for ammonia.
The permeability, P, can then be estimated if the capillary surface area per gram is known. A value of 100 cm 2 /g for capillary surface area was estimated from the value of human cortex of 190 cm ! /cm 3 and 57 cm 2 /cm 3 for white matter. 23 This yields an estimate of P of 4 X 10~6 cm/sec.
E versus BloodpH
The values of E measured over a blood pH range of 7.20 to 7.68 (NH 3 /NH4 + change of 1.7 to 4.6%) are shown in table 2. In animals 1 and 2 the extraction of ammonia was measured at base line pH, increased with NaOH and then decreased with HC1. The blood pH of animal 3 was only increased from the base line value with NaOH. No correlation was found between arterial blood pH and E when Paco 2 and blood ammonia concentration were held constant. The absolute values of E for animals 1 and 3 were different from animal 2, but this was due to the different levels of Paco 2 (eg. different values of CBF). 85  47  22  74  57  48  31  71  23  41  25  61  86  108  20  31  38  24  36  51  59  46  52  57  42  48  45  41  41  50   E  (%)  64  24  34  54  8  25  34  48  17  58  42  58  31  21  15  72  59  38  55  46  28  28  32  28  21  46  45  34  50  38  30 Mgm/ 100ml at a constant Paco 2 and arterial blood pH. No significant change in E was observed over this ammonia concentration range (table 3) .
E versus Arterial Blood Ammonia Concentration
FIGURE 2. A) Extraction fraction, E, as a function of CBF which shows an inverse relationship. These data can be fit with the linear equation (P < 0.001) but there appears to be a non-linear relationship as would be predicted by eq. 2. B) Plot of Infl-E) versus 1 /CBF. These data are used to calculate the permeability-surface area product (PS) oj""A'-ammonia in brain (eq. 2). Solid line represents a linear leastsquare best fit to data (r = .94, P < 0.001) as given by eq. 3.
E versus Glucose and Oxygen Utilization and Elevated Blood Ammonia Concentration
E was measured in 8 rhesus monkeys at a) normal levels of cerebral metabolic rate for glucose and oxygen, b) a low insulin induced CMRGlu and CMRO 2 , and c) a low insulin induced level of arterial blood glucose concentration and elevated blood ammonia concentration from the infusion of NH 4 •Arterial blood pH was changed with I.V. infusion of HC1 or NaOH. **Ratio of NH, to NH,+ was computed using a plasma pK. of 9.02 (24). In assessing the effect on E due to changes in CMRGlu, CMRO 2 and arterial blood ammonia concentration, the effect of variable CBF must be removed. This was done by using a least-squares fit to the data shown in figure 2A to normalize E to the base line value of CBF. In animals 1, 3, 5 and 8 this was a negligible correction, but in the rest of the animals it was an appreciable correction.
Discussion
Brain Permeability for Ammonia
The data in table 1 and figure 2A indicate that ammonia is not normally 100% extracted by cerebral tissue and that there is a strong inverse relationship between the extraction fraction, E, and CBF. It would appear that brain capillary permeability limitation for ammonia (eqs. 3 and 4) is responsible for this behavior. However there are a number of possible rate limiting steps in the passage of ammonia from blood into the brain extracellular fluid space that must be considered. These factors are: 1) the rate of chemical exchange between the diffusable unionized form, NH 3 , and the relatively impermeable ionized form of NH 4 + in blood, 2) trapping by red cells, 3) binding of ammonia by plasma protein, and 4) permeability-diffusion limitation of the blood brain barrier (BBB) to NH 3 and NH 4 + ,
Chemical Equilibrium
Of the two chemical forms of ammonia (NH 3 and NH 4 + ) only the unionized NH 3 freely permeates the BBB and diffuses into the cerebral tissue." The relative proportion of NH 3 and NH 4 + in blood is determined by the pH. For example, using a pK a for ammonia in plasma equal to 9.02" the percentage of unionized ammonia at pH 6, 7, and 8 is approximately 0.1, 1, and 10%, respectively. Thus, at a normal pH of 7.3-7.4 the majority of blood ammonia is in the form of NH 4 +. When the equilibrated mixture, "NH 3 c " N H / , is injected into the ICA the 13 NH 3 diffuses through the BBB and the chemical equilibrium is upset. Thus, the 13 NH 4 + must be converted into 13 NH 3 to allow it to continuously cross the BBB. The rate of chemical exchange between the 2 forms of ammonia could be a rate limiting step. However, considering the forward and reverse rate constants for the interconversion of ammonia between its 2 forms, 25 it only takes about 19 fisec to convert NH 4 + to NH 3 when the equilibrium is upset (eg. if concentration of NH 3 was reduced to 0). Thus this does not appear to be a rate limiting step. This is further substantiated by the fact that the value of E did not change when the arterial blood pH was varied from 7.2 to 7.7 even though this produced a factor of 3 change in the ratio of NH 3 to NH 4 + (table 2) . Thus the ratio of unionized to ionized ammonia or the chemical exchange between these forms does not appear to be a rate limiting step when compared to the transit time of blood through the
TABLE 4 Effect on Extraction Fraction of l 'N-Ammonia {E) of Insulin induced Hypoglycema Without and With Increased Blood Ammonia Concentration
Initial Conditions
Arterial Blood Glucose (mg%) CMRGlu (mg/min/100 gms) C M R d (ml/min/100 gms) Arterial Blood Ammonia (Mgm/100 ml) CBP (ml/min/100 gms)
Reduced Arterial Blood Glucose:
Arterial Blood Glucose (mg%) CMRGlu (mg/min/100 gms) CMRO, (ml/min/100 gms) Arterial Blood Ammonia (Mgm/100 ml) % Change in E* CBP (ml/min/100 gms) brain of 2 to 6 seconds at the CBF levels employed in this study. 21 
Retention by Red Blood Cells and Plasma Proteins
A rate limiting factor could result from a significant amount of 13 N-ammonia in the red blood cells or bound to proteins in the blood. However, we observed no significant change in E when 13 N-ammonia was injected with isolated red blood cells, plasma or physiologic saline. In addition, Klocke et al. 26 have shown that the permeability of the erythrocyte membrane to ammonia is approximately 1.08 X 10" 2 cm/sec and that ammonia equilibrates with the surrounding medium in approximately 100 milliseconds which is short relative to the brain blood transit time. 21 Jacquez et al." have reported that ammonia binds to plasma proteins since they found that ammonia solubility in plasma was greater than that calculated for ammonia in water. As noted by Klocke et al., 26 in the calculations of Jacquez et al., 27 an extrapolation of an ammonia pressure of 1 mm of mercury to their data obtained at 1 atmosphere of pressure was made using Henry's law which does not apply at high pressures. Therefore the extrapolation of Jacquez is probably not valid. Furthermore, Bates and Pinching 28 have reported solubility values at low ammonia tensions in water to be identical to those measured in plasma which indicates that plasma protein binding of ammonia must be very small.
Permeability Coefficient
The capillary permeability coefficient measured in this work of 4 X 10' 6 cm/sec does appear as a rate limiting step. As mentioned above, the permeability of ammonia through the lipid membrane of human erythrocytes has been studied by Klocke et al. 26 who found a value of 1.08 X 10 2 cm/sec with an equilibration time of surrounding saline solution of about 100 milliseconds. However, the permeability of erythrocytes for water is reported to be 0.33 X 10~2 cm/ sec, 29 -3° whereas recently the permeability of H 2 O in brain (rhesus monkey) has been measured using H 2 16 O"' 31 to be 1.9 X 10 4 cm/sec. Thus the water permeability of the BBB is less than erythrocytes and this appears to be true also for ammonia. One significant difference between the BBB and erythrocytes is that in the latter, one is measuring the permeability across the single membrane whereas in the former there are probably multiple membranes that must be crossed (for example, membranes of endothelial and glial cells).
The permeability limitations of ammonia through the lipid membrane of the BBB is probably in large part determined by the low lipid solubility of ammonia. 32 Raichle, Eichling et al." have shown an excellent correlation between the lipid solubility (oil-water partition coefficients) and the BBB permeability for various alcohols. Since lipid solubility is a major factor in determining the BBB permeability, it is not surprising that ammonia is not 100% extracted in the brain since its lipid solubility is about 4 to 100 times less than the alcohols studied by Raichle, Eichling et al. which are also not 100% extracted by the brain in the CBF range studied in this work.
To examine whether ammonia was transported through the BBB by a carrier mediated transport mechanism the blood ammonia level was elevated from a normal level of 80 to 100 ngms/lOOml to levels as high as 1342 jtgms/lOOml. However no change in E was observed over this concentration range indicating that the transport mechanism is not carrier mediated or that we did not reach saturation levels. The elevated blood level of ammonia should also slow down the turnover rate of the free ammonia tissue pool. Since E didn't change, this doesn't seem to be an important factor except that the elevated tissue ammonia concentration could have accelerated the turnover rate by a detoxification shunt (eg. through a-ketogluterate to amino acids).
Brain Retention of Ammonia
An important feature of the behavior of l3 N-ammonia is its retention by brain for a prolonged period of time. The l3 N-ammonia that permeates the BBB and diffuses into the free ammonia tissue pool is immediately equilibrated between 13 NH 3 and 13 NH 4 + . The free ammonia pool in the brain is known to be small, approximately 15 /iinoles/lOOgms and turns over at a rate of 75%/sec 33 by incorporation of ammonia into amino acids through a-ketogluterate in the citric acid cycle. From figure 1 it is clear that the amount of 13 NH 3 that passes into the brain is retained and cleared at a very slow rate (T w = 40-»50 min). This would indicate that the major portion of "N is bound into the products of ammonia metabolism. Thus, it was thought that by decreasing the metabolic rate for glucose and elevating the blood ammonia level the concentration would increase and the turnover rate of the free ammonia tissue pool (extracellular-extravascular) would slow down. If these factors were involved in determining E, one would expect to observe a decrease in E. However, when the rate of glucose and oxygen utilization was decreased (at normal blood ammonia concentration) by an average value of 54% by an in-STROKE VOL 8, No 6, NOVEMBER-DECEMBER 1977 sulin induced hypoglycemic condition, the value of E dropped by only an average value of 24% (table 5) . With the animals in a state of hypoglycemia, blood ammonia concentration was elevated from an average value of about 60 to 760 /igms/ 100ml in an effort to further slow down the turnover rate of the free ammonia pool by increasing its concentration. In this latter state the value of E did not significantly change from the value in the previous state (table 5) . Even though arterial blood glucose concentration remained at low values (average of 27 mg%) and CMRO 2 remained low, the value for CMRGlu increased by a factor of about 2.2. This is indicative of a detoxification shunt for ammonia through a-ketogluterate in the citric acid cycle. This is also supported by the fact that the oxygen demand did not increase which is consistent with the low oxygen requirements in metabolism of glucose to a-ketogluterate without further metabolism through the citric acid cycle. This latter observation was also made by McKhann and Tower 34 in studies of ammonia toxicity in oxidative metabolism with tissue slices of cat cerebral cortex in which elevated ammonia levels produced a reduction in CMRO 2 and increases in CMRGlu over control values.
The fact that the value of E did not return to the initial value as did the value for CMRGlu during the reduced arterial blood glucose and elevated blood ammonia level study probably results from the fact that even though the CMRGlu increased the rate of ammonia utilization, this was probably offset by an increase in the free tissue ammonia pool concentration due to the elevated blood ammonia level. However, there is a very poor understanding of ammonia metabolism and ammonia detoxification shunts during elevated blood ammonia levels such as occurs in conjunction with liver disease and hepatic coma.
Equilibrium Imaging
Phelps et al. 8 have used intravenous injections of l3 Nammonia with positron emission transaxial tomography to evaluate its application as a hemodynamic indicator in the brain. These studies were based upon the assumptions that 13 N-ammonia would 1) distribute through the brain in proportion to the blood perfusion, 2) be extracted from the blood into the tissue through the diffusable form of NH 3 , 3) be rapidly incorporated into glutamine because of the rapid turnover of the free ammonia pool in cerebral tissue, 4) once incorporated into the glutamine pool would be effectively retained or trapped in the brain for an appreciable period of time due to the large size and slow turnover rate of the glutamine pool 35 -36 as shown in figure 3 . This slow turnover rate of the trapped 13 N would then allow the imaging of the cross-sectional distribution with the positron tomograph. This approach has: (1) allowed clear delineation of ischemic cerebral and myocardial infarcts, 9 -10 -3 ' (fig. 4) , (2) shown high uptake in cerebral lesions with demonstrated high perfusion, 9 -10 (3) shown a deficit in an ischemic infarct which had high uptake surrounding the ischemic region (i.e. apparent hyperemia). (Seven days later, patient showed significant improvement and a repeat study demonstrated a 30% higher uptake of 13 NH 3 in the previously ischemic zone relative to the contralateral side even though there was a 39% decrease in glucose metabolism as tomographically measured with I8 F-2-deoxyglucose. 38 ) This approach has also shown (4) high 13 NH 3 uptake in superficial cortex, internal grey nuclei, cerebellum and brain stem relative to subcortical white matter 9 -l0 -37 ( fig. 4) , (5) shown excellent agreement between the ratio of l3 NH 3 uptake and glucose metabolic rate (tomographically measured with 18 F-2-deoxyglucose) in the superficial cortex, internal grey nuclei, cerebellum and subcortical white matter in normal human subjects. 38 The data from this study allow one to propose an interpretation of the equilibrium 13 N-ammonia images. Since ammonia is not 100% extracted by cerebral tissue in a single pass and is in fact inversely related to CBF, the question is raised as to whether the tomographic equilibrium images represent a cross-sectional distribution of CBF. However, if one assumes that all the capillaries in the brain have uniform permeability and that the ammonia concentration per capillary is the same, then the amount of 13 N-ammonia extracted and retained in cerebral tissue is proportional to the capillary density. The ratio Of l3 N-ammonia uptake and retention in cerebellum, brain stem and superficial cortex to the value of subcortical white matter is in excellent agreement with the capillary density data by Lierse and Horstmann. 39 Thus, as discussed earlier by Phelps et al., 9 regional differences in the concentration of 13 N-ammonia ( fig. 4 ) would reflect variations of capillary density.
The interpretation of the equilibrium images of 13 Nammonia as representing the distribution of capillary density is based upon the assumption that the capillary permeability for ammonia has not been altered and that the trapping mechanism of amino acid metabolism is intact. Any deviation from these assumptions, such as might occur with cerebral pathology, may alter the interpretation of the images. Since the mechanism for capillary flow changes in the brain (i.e. dilation-constriction, capillary recruitment or rapid opening and closing of capillary vessels) and the quantitative relationship between capillary density and CBF is not well known it is difficult to relate the distribution of tissue 13 N-ammonia uptake and retention with CBF. More detailed studies are required to allow the explicit interpretation of the equilibrium 13 N-ammonia distribution in abnor- mal cerebral tissue. However, as discussed earlier, 9 13 Nammonia appears to be well suited to the delineation of ischemic infarction and capable of providing early detection of cerebral tissue perfusion defects with PCT.
Experimental Cerebral Vasospasm After
Subarachnoid Hemorrhage This experimental study suggests the existence of a vasospasmogenic substance in the blood in the subarachnoid space. Activity begins about 3 days after subarachnoid hemorrhage, increases strongly at 5 to 10 days, and disappears after 15 days.
VASOSPASM associated with subarachnoid hemorrhage (SAH) from a ruptured intracranial aneurysm plays an important role in determining prognosis. However, not only the prevention, but also the true nature and cause of vasospasm remains unclear.
We based this experiment upon the hypothesis that a vasospasmogenic substance might be produced from the blood components in the subarachnoid space by sequential chemical changes and be temporally related to clinical data which suggest that vasospasm develops about 7 days after SAH. Experimental vasospasm was induced in the basilar arteries of cats by applying fresh blood or blood and cerebrospinal fluid (CSF) mixtures incubated for various From the Division of Neurosurgery, Institute of Brain Diseases, Tohoku University School of Medicine, 5-13-1, Nagamachi, Sendai, Japan. durations at 37°C. The frequency and severity of vasospasm and its correlation with the incubation time of the mixtures was studied. Results are discussed mainly with regard to the developmental time of vasospasm after SAH and to the possibility of the existence of a vasospasmogenic substance.
Methods
Fifty-seven adult cats weighing from 2.5 to 5.0 kg, were anesthetized with intramuscular pentobarbital, and placed on an electric temperature-controlled surgical table. Tracheostomies were performed. Spontaneous respiration was permitted. Body temperature, femoral arterial pressure, respiratory rate and acid-base balance were measured. In experiments lasting more than 3 hours, a polyethylene catheter was placed in the femoral vein for infusions.
By the transcervical, transclival approach, a bone window
